 |
43 Diseases |  |
13 Trials |
|
13 Trials |  |
341 News |  |
| «12345 |
- | hydroxyzine hydrochloride / Generic mfg., levocetirizine / Generic mfg.
Trial completion: LevoHydroxy: Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Levocetirizine Alone in High Doses (clinicaltrials.gov) - Jul 14, 2013
P4, N=24, Completed, Sponsor: Association Asthma, Bulgaria
Recruiting --> Completed
- Avastin (bevacizumab) / Roche
Enrollment open, Combination therapy: Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer (clinicaltrials.gov) - May 13, 2013
P2, N=36, Recruiting, Sponsor: Washington University School of Medicine
Recruiting --> Completed Not yet recruiting --> Recruiting
- Avastin (bevacizumab) / Roche
New P2 trial, Combination therapy: Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer (clinicaltrials.gov) - Nov 4, 2012
P2, N=36, Recruiting, Sponsor: Washington University School of Medicine
- ||||||| levocetirizine / Generic mfg.
Trial completion: Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics (clinicaltrials.gov) - Sep 19, 2012
P3, N=60, Completed, Sponsor: GlaxoSmithKline
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||| Omnaris (ciclesonide nasal spray) / Covis Pharma, Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center
Enrollment change: Omnaris Versus Levocetirizine Phase 4 Study (clinicaltrials.gov) - Sep 4, 2012
P4, N=349, Completed, Sponsor: Handok Pharmaceuticals Co., Ltd.
Recruiting --> Completed N=237 --> 349
- |||| Omnaris (ciclesonide nasal spray) / Covis Pharma, Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center
Trial completion: Omnaris Versus Levocetirizine Phase 4 Study (clinicaltrials.gov) - Sep 4, 2012
P4, N=349, Completed, Sponsor: Handok Pharmaceuticals Co., Ltd.
N=237 --> 349 Recruiting --> Completed
- levocetirizine / Generic mfg.
Trial termination: The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism (clinicaltrials.gov) - Aug 7, 2012
P=N/A, N=11, Terminated, Sponsor: Wake Forest School of Medicine
Recruiting --> Completed Recruiting --> Terminated; Mediators of interest were not consistently detectable with the analytical methods employed.
- levocetirizine / Generic mfg.
Enrollment change: The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism (clinicaltrials.gov) - Aug 7, 2012
P=N/A, N=11, Terminated, Sponsor: Wake Forest School of Medicine
Recruiting --> Terminated; Mediators of interest were not consistently detectable with the analytical methods employed. N=20 --> 11
- | cetirizine oral / Generic mfg., levocetirizine / Generic mfg.
New P1 trial: Pharmacokinetic Study of Levocetirizine Oral Solution (clinicaltrials.gov) - Jun 17, 2012
P1, N=20, Completed, Sponsor: GlaxoSmithKline
- fexofenadine / Generic mfg., levocetirizine / Generic mfg.
New P1 trial: LAWAF: Safety Study of Levocetirizine and Fexofenadine (clinicaltrials.gov) - Apr 22, 2012
P1, N=18, Completed, Sponsor: Charite University, Berlin, Germany
- |||||||||| levocetirizine / Generic mfg.
New P3 trial: Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics (clinicaltrials.gov) - Mar 22, 2012
P3, N=60, Completed, Sponsor: GlaxoSmithKline
- hydroxyzine hydrochloride / Generic mfg., levocetirizine / Generic mfg.
New P4 trial: Effects of Levocetirizine and Hydroxyzine on Cognitive and Psychomotor Functioning During Simulated Diving (clinicaltrials.gov) - Dec 19, 2011
P4, N=24, Completed, Sponsor: Utrecht Institute for Pharmaceutical Sciences
- ||||| Omnaris (ciclesonide nasal spray) / Covis Pharma, Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center
New P4 trial: Omnaris Versus Levocetirizine Phase 4 Study (clinicaltrials.gov) - Sep 6, 2011
P4, N=349, Completed, Sponsor: Handok Pharmaceuticals Co., Ltd.